Yixin Wang

State Key Laboratory Of Medical Genomics
Shanghai, 200025, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Enhancing Anti-Tumor Effects of Engineered Extracellular Vesicles via Endocytosis Route Switching and Interferon Response Suppression.

Enhancing Anti-Tumor Effects of Engineered Extracellular Vesicles via Endocytosis Route Switching and Interferon Response Suppression.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: August 14, 2025

Exploring potential causal effects of circulating inflammatory proteins on hematologic malignancies and identifying cross-cancer drug targets: a Mendelian randomization study.

Exploring potential causal effects of circulating inflammatory proteins on hematologic malignancies and identifying cross-cancer drug targets: a Mendelian randomization study.

Journal: Hematology (Amsterdam, Netherlands)

Published: July 31, 2025

Single-cell multi-omic analyses highlight the essential role of NKX2.2-CLEC16A/endosomal pathway for human pancreatic differentiation and function.

Single-cell multi-omic analyses highlight the essential role of NKX2.2-CLEC16A/endosomal pathway for human pancreatic differentiation and function.

Journal: Cell reports

Published: April 02, 2025

Healthy lifestyles and risk of major non-communicable chronic diseases and mortality in individuals with metabolic syndrome.

Healthy lifestyles and risk of major non-communicable chronic diseases and mortality in individuals with metabolic syndrome.

Journal: The journal of nutrition, health & aging

Published: March 26, 2025

Establishment of a prognostic model based on ER stress-related cell death genes and proposing a novel combination therapy in acute myeloid leukemia.

Establishment of a prognostic model based on ER stress-related cell death genes and proposing a novel combination therapy in acute myeloid leukemia.

Journal: Journal of translational medicine

Published: February 27, 2025

Improved CAR internalization and recycling through transmembrane domain optimization reduces CAR-T cytokine release and exhaustion.

Improved CAR internalization and recycling through transmembrane domain optimization reduces CAR-T cytokine release and exhaustion.

Journal: Frontiers in immunology

Published: November 20, 2024

Correction: Arsenic trioxide and p97 inhibitor synergize against acute myeloid leukemia by targeting nascent polypeptides and activating the ZAKα-JNK pathway.

Correction: Arsenic trioxide and p97 inhibitor synergize against acute myeloid leukemia by targeting nascent polypeptides and activating the ZAKα-JNK pathway.

Journal: Cancer gene therapy

Published: October 21, 2024

ROR1 CAR-T cells and ferroptosis inducers orchestrate tumor ferroptosis via PC-PUFA2.

ROR1 CAR-T cells and ferroptosis inducers orchestrate tumor ferroptosis via PC-PUFA2.

Journal: Biomarker research

Published: October 15, 2024

The nuclear factor-κ B inhibitor SN50 enhances the efficacy of B-cell maturation antigen-targeted chimeric antigen receptor T-cell therapy.

The nuclear factor-κ B inhibitor SN50 enhances the efficacy of B-cell maturation antigen-targeted chimeric antigen receptor T-cell therapy.

Journal: Haematologica

Published: September 21, 2024

Changes in Symptom Clusters Over the Course of Chemotherapy in Children With Acute Lymphoblastic Leukemia: A Longitudinal Survey.

Changes in Symptom Clusters Over the Course of Chemotherapy in Children With Acute Lymphoblastic Leukemia: A Longitudinal Survey.

Journal: Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners

Published: August 21, 2024

The enhancement of immunoactivity induced by immunogenic cell death through serine/threonine kinase 10 inhibition: a potential therapeutic strategy.

The enhancement of immunoactivity induced by immunogenic cell death through serine/threonine kinase 10 inhibition: a potential therapeutic strategy.

Journal: Frontiers in immunology

Published: June 19, 2024

Arsenic trioxide and p97 inhibitor synergize against acute myeloid leukemia by targeting nascent polypeptides and activating the ZAKα-JNK pathway.

Arsenic trioxide and p97 inhibitor synergize against acute myeloid leukemia by targeting nascent polypeptides and activating the ZAKα-JNK pathway.

Journal: Cancer gene therapy

Published: February 28, 2024

Showing 1-12 of 14

Last Updated: 09/26/2026